Luoxin Pharmaceuticals Group Stock Balance Sheet Health
Financial Health criteria checks 1/6
Luoxin Pharmaceuticals Group Stock has a total shareholder equity of CN¥2.2B and total debt of CN¥1.9B, which brings its debt-to-equity ratio to 86%. Its total assets and total liabilities are CN¥4.9B and CN¥2.7B respectively.
Key information
86.0%
Debt to equity ratio
CN¥1.85b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥684.91m |
| Equity | CN¥2.15b |
| Total liabilities | CN¥2.74b |
| Total assets | CN¥4.89b |
Recent financial health updates
Recent updates
Luoxin Pharmaceuticals Group Stock Co., Ltd. (SZSE:002793) Held Back By Insufficient Growth Even After Shares Climb 41%
Oct 21
Why Investors Shouldn't Be Surprised By Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (SZSE:002793) Low P/S
Aug 23Luoxin Pharmaceuticals Group Stock (SZSE:002793) Is Making Moderate Use Of Debt
Jun 25Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (SZSE:002793) Price Is Right But Growth Is Lacking After Shares Rocket 25%
May 21Subdued Growth No Barrier To Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (SZSE:002793) Price
Feb 28Financial Position Analysis
Short Term Liabilities: 002793's short term assets (CN¥2.0B) do not cover its short term liabilities (CN¥2.4B).
Long Term Liabilities: 002793's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥328.4M).
Debt to Equity History and Analysis
Debt Level: 002793's net debt to equity ratio (54.2%) is considered high.
Reducing Debt: 002793's debt to equity ratio has increased from 29.8% to 86% over the past 5 years.
Debt Coverage: 002793's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 002793's interest payments on its debt are well covered by EBIT.